Clinical Experience in Adults and Children Treated with Intravenous Peramivir for 2009 Influenza A (H1N1) Under an Emergency IND Program in the United States

(See the editorial commentary by Jain et al, on pages 707–709.) Background. Peramivir, an investigational intravenous neuraminidase inhibitor in Phase 3 trials for hospitalized patients, was made available during the 2009 H1N1 influenza pandemic under the Emergency Investigational New Drug (eIND) re...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hernandez, Jaime E., Adiga, Raghavendra, Armstrong, Robert, Bazan, Jose, Bonilla, Hector, Bradley, John, Dretler, Robin, Ison, Michael G., Mangino, Julie E., Maroushek, Stacene, Shetty, Avinash K., Wald, Anna, Ziebold, Christine, Elder, Jenna, Hollister, Alan S., Sheridan, William
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2011
Assuntos:
Articles and Commentaries
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3049340/
https://ncbi.nlm.nih.gov/pubmed/21367722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cir001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados